Switzerland-based Medacta designs joint and spine surgery products for the outpatient setting.
Here are four insights:
1. In the next 10 years, outpatient knee replacements are anticipated to increase by more than 450 percent and outpatient hip replacement will boost by more than 630 percent nationally.
2. To meet this increasing outpatient demand, Medacta presents the Propel Same Day Surgery Initiative, which combines products with education programs.
3. The Propel Same Day Surgery Initiative encompasses four steps for surgeons and administration:
• Product introduction: Medacta presents its products, such as the Anterior Minimally Invasive Surgery Program for total hip replacement; MyKnee and MySpine 3-D Patient-Matched technologies and GMK Efficiency Single Use Instruments for knee replacement.
• Propel Reference Center visit: Best practices for using Medacta products for same-day surgery
• Learning center: Surgeons practice surgical techniques using the company's products in a cadaveric training facility.
• Scheduling: Surgeons schedule procedures in their facilities with a Propel Reference Center surgeon proctor
4. Surgeons have utilized Medacta's AMIS system in more than 250,000 total hip replacements and the company's MyKnee in 50,000 knee replacements.
More articles on devices:
Spineology's Elite Expandable Interbody Fusion System granted expanded FDA clearance — 5 details
SpineGuard and Zavation's DSG SmartScrew offer one-step insertion — 6 key notes
Stryker launches Mako total knee replacement application: 5 key notesttp://newsroom.vizientinc.com/newsletter/research-and-insights-news/outpatient-joint-replacement-unnecessary-concern-or-market-rea